Funding for this research was provided by:
agence nationale de la recherche (ANR-17-ENM3-0005-01)
ministerio de ciencia e innovación (PCIN-2017-090)
horizon 2020 (764958)
european regional development fund (SMART platform)
Instituto de Salud Carlos III (AC17/00004, FI17/00073)
Generalitat de Catalunya (2017-SGR-1427, SLT017/20/000197)
Received: 28 June 2021
Accepted: 25 September 2021
First Online: 26 October 2021
: Informed consent was obtained from all subjects with the approval of the Clinical Ethics Committee of the Hospital Vall d’Hebron (PR-AG-177-2011/2021). Collection of human umbilical cord blood was done with the signature of a consent form by infant’s parents, in compliance with the French legislation. The protocol was approved by the French Ministry of Higher Education and Research (CODECOH Number DC2011-1321). All experiments were carried out in accordance with the approved protocol.
: Not applicable.
: PB, AK, and MM are employees of Pure Biologics S.A. Authors report no competing interests.